Clinical trial of APMV2020 in Covid 19 subjects
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2021/06/034254
- Lead Sponsor
- Meyer Organics Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 320
1.Age -18- 60 years (Both sex)
2.Confirmed COVID 19 patient with positive RT-PCR
3.Mild symptomatic patients having no signs of severe disease (NEWS score �6)
4.Home/ institutional quarantined subjects with no necessity of dedicated hospital admission at the time of screening
5.Subject willing to provide consent and follow up for study duration
1.Patients with autoimmune disease or self-reports HIV or syphilis infection
2.Subject suffering from disorders where Aspirin is contraindicated and/or as per the discretion of investigator
3.Proves to be unfit for the study as per the investigatorââ?¬•s discretion
4.Pregnant or lactating women
5.Requiring hospital admission at screening
6.Any other comorbidity which is critical stage at screening which in investigator discretion finds subject not suitable for the trial participation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method